Clinical Trials on Urinary Biomarker

Total 59688 results

Astellas Pharma Inc

Completed

A Study of YM178 in Patients With Symptomatic Overactive Bladder

Urinary Bladder, Overactive

Japan
Federal University of Health Science of Porto Alegre

Unknown

Effects of TENS in Autonomous System in Women With Overactive Bladder

Urinary Bladder, Overactive

Brazil
Astellas Pharma Inc

Completed

A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB) (VENUS)

Urinary Bladder, Overactive

United States
Astellas Pharma Inc

Completed

Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency Symptoms (SUNRISE)

Urinary Bladder, Overactive

France, United Kingdom, Belgium, Germany, Spain, Portugal, Greece, Russian Federation, Czech Republic, Poland, Hungary, Italy, Slovakia, Egypt
Uroplasty, Inc

Completed

Modified Extension Study to the SUmiT Trial: Evaluation of Long Term Therapy With Percutaneous Tibial Nerve Stimulation (PTNS) for Overactive Bladder Symptoms (STEP)

Urinary Bladder, Overactive

United States
Clínica Infantil Colsubsidio

Unknown

Management of the Idiopathic Overactive Bladder With Botulinum Toxin: Systematic Review

Urinary Bladder, Overactive

Colombia
EMKinetics, Inc

Terminated

Pulsed Electromagnetic Stimulation for Treatment of Overactive Bladder

Urinary Bladder, Overactive

United States
Pfizer

Completed

UK Study Assessing Flexible Dose Fesoterodine in Adults (SAFINA)

Urinary Bladder, Overactive

United Kingdom
Pfizer

Completed

A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic Monitoring

Urinary Bladder, Overactive

Korea, Republic of
Wake Forest University Health Sciences

Terminated

At Home Early vs. Delayed Catheter Removal Following Failed Postoperative Voiding Trial: a Randomized Trial (AHEADCARE)

Urinary Retention Postoperative

United States
University of Michigan

Terminated

Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients

Postoperative Urinary Retention

United States
Rambam Health Care Campus

Unknown

Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity

Overactive Bladder | Enuresis | Urge Urinary Incontinence | Self Clean Intermittent Catheterization

Israel
OxThera

Terminated

An Extension Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria (ePHex-OLE)

Hyperoxaluria, Primary

United Kingdom, Spain, Belgium, United States, Germany, Tunisia
Mayo Clinic

Completed

Primary Hyperoxaluria Mutation Genotyping/Phenotyping

Primary Hyperoxaluria

United States
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Oxalosis...

Completed

Primary Hyperoxaluria Mutation Genotyping

Primary Hyperoxaluria

United States
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Withdrawn

Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria

Hyperoxaluria
OxThera

Completed

A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria

Primary Hyperoxaluria

France, United Kingdom, Spain, Belgium, United States, Germany, Tunisia
Biocodex

Completed

Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria

Primary Hyperoxaluria

France
OxThera
FP7-SME-2013 Research for the benefit of SMEs program

Completed

Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria

Primary Hyperoxaluria

France, Germany, United Kingdom
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Orphan...

Completed

Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria

Hyperoxaluria

United States
Far Eastern Memorial Hospital

Recruiting

Therapeutic Efficacy in Women With Stress Urinary Incontinence

Women With Stress Urinary Incontinence

Taiwan
London Health Sciences Centre
Canadian Urological Association

Recruiting

Can Probiotics be Used in the Prevention of Recurrent UTI in Paediatric Neurogenic Bladder

Urinary Tract Infection

Canada
Kristine Zinkgraf
Medical College of Wisconsin; WomenConnected

Completed

Effects of Topical Lidocaine During Urodynamic Testing In Women

Pain | Urinary Stress Incontinence
Renalis
University Hospitals Cleveland Medical Center

Recruiting

Treatment of Overactive Bladder With a Digital Conversational Agent: the MOTIVATION Study (MOTIVATION)

Overactive Bladder | Pelvic Floor Disorders | Urge Incontinence

United States
Shanghai Yueyang Integrated Medicine Hospital

Completed

Evaluation of Integrated Optimization Schemes for Female Stress Incontinence (EIOSFSI)

Stress Urinary Incontinence in Women

China
Mansoura University

Completed

Pharmacological Enhancement for Nocturnal Incontinence in Orthotopic Bladder Substitute

Urinary Incontinence | Urinary Bladder Cancer | Incontinence

Egypt
Second Affiliated Hospital, School of Medicine,...
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine; First Affiliated Hospital of Wenzhou Medical University

Unknown

The Safety and Efficacy of Micro-energy Ultrasound Therapy in the Treatment of Female Stress Urinary Incontinence

Female Stress Urinary Incontinence

China
Sciton

Completed

Hybrid Fractional Laser Treatment for Symptoms of Urinary Incontinence

Urinary Incontinence | Stress Urinary Incontinence | Urge Incontinence

United States
Federal University of São Paulo

Completed

A Comparative Study Minisling Versus Transobturator (TOT)Sling (sui)

Female Stress Urinary Incontinence

Brazil
C. R. Bard

Completed

Clinical Evaluation of Ajust™ in Stress Urinary Incontinence (CEASe)

Female Stress Urinary Incontinence

United States
Sheba Medical Center
Kaplan Medical Center; The Baruch Padeh Medical Center, Poriya

Unknown

Safety and Efficacy of Carbone Dioxide (CO2) Laser System in Treatment of Female Stress Urinary Incontinence. (CO2)

Female Stress Urinary Incontinence
Eunice Kennedy Shriver National Institute of Child...

Terminated

Refractory Urge Incontinence and Botox Injections

Urinary Incontinence | Urinary Urgency | Urge Urinary Incontinence | Detrusor Overactivity

United States
American Medical Systems

Unknown

MiniArc Study: Long-Term Effectiveness Trial for AMS Sling Systems (MiniArc)

Stress Urinary Incontinence in Women

United States
Allergan

Completed

Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)

Urinary Bladder, Overactive

United States
FemPulse Corporation

Completed

FemPulse Therapy First-in-Human Experience

Urinary Bladder, Overactive

United States
Merck Sharp & Dohme LLC

Completed

A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008)

Urinary Bladder, Overactive
National Taiwan University Hospital

Completed

Age-specific Prevalence and Comparisons of UDS and Bladder Diary Between OAB-wet and -Dry Women

Urinary Bladder, Overactive
Astellas Pharma Inc

Completed

Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents

Urinary Bladder, Overactive

Sweden, United Kingdom, Belgium, Denmark
Pfizer

Completed

A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy Volunteers

Urinary Bladder, Overactive

Singapore
KYU-SUNG LEE
Astellas Pharma Korea, Inc.

Completed

A Study Comparing the Efficacy of an Alpha Blocker Versus an Alpha Blocker Plus Solifenacin in Men With Overactive Bladder

Urinary Bladder, Overactive

Korea, Republic of
Astellas Pharma Inc

Completed

Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder (VERSUS)

Urinary Bladder, Overactive

United States
Astellas Pharma Inc

Completed

Solifenacin Succinate Versus Tolterodine 4mg Once Daily (STAR)

Urinary Bladder, Overactive

France, United Kingdom, Spain, Belarus, Belgium, Ukraine, Denmark, Greece, Russian Federation, Czech Republic, Netherlands, Germany, Hungary, Italy, Slovakia, Sweden, Norway
Pfizer

Completed

Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder

Urinary Bladder, Overactive

Portugal
Pfizer

Terminated

Non-Interventional Study To Investigate Whether Information Provided To Patients Influences Their Satisfaction With Toviaz Therapy

Urinary Bladder, Overactive
Pfizer

Completed

Special Investigation For Long Term Use Of Tolterodine (Regulatory Post Marketing Commitment Plan).

Urinary Bladder, Overactive
Rambam Health Care Campus

Unknown

Solifenacin Succinate Versus Fesoterodine A Comparison Trial for Urgency Symptoms

Urinary Bladder, Overactive

Israel
Omeros Corporation

Completed

Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urinary Tract-Located Stones

Urinary Calculi | Urinary Stones | Urinary Tract Stones

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Trial of HR19042 Capsule in Healthy Chinese Subjects

Primary IgA Nephropathy

China
National Foundation for Fertility Research
Fertility Laboratories Of Colorado

Terminated

In Vitro Follicle Activation (IVA)

Infertility | Primary Ovarian Insufficiency

United States
National Cancer Institute (NCI)

Recruiting

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma

Lymphoma, Primary Effusion

United States

Clinical Trials on Urinary Biomarker

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations